CAD
GLMD icon

Craig A. Drill’s Galmed Pharmaceuticals GLMD Stock Holding History

Craig A. Drill’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14
Closed -$90K – 14
2016
Q2 		$90K Buy
14
+7
+100% +$52.9K 0.18% 14
2016
Q1 		$49K Buy
+7
New +$54.9K 0.12% 15
2015
Q3 		– Sell
-11
Closed -$160K – 24
2015
Q2 		$160K Sell
11
-65
-86% -$904K 0.23% 18
2015
Q1 		$1.03M Buy
+76
New +$913K 1.17% 13

Other funds holding GLMD

6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $131M AUM 35.16% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $126M AUM 15.32% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
WJA
Williams Jones & Associates New York $4.82B AUM 19.95% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.46B AUM 33.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Craig A. Drill's GLMD Position: Q3 2016 in Review

Craig A. Drill sold out of Galmed Pharmaceuticals (GLMD) in Q3 2016, closing a stake of 14 shares — an estimated $90K sold.

Craig A. Drill first reported a position in GLMD in Q1 2015 and held it in 4 quarters. The position peaked at $1.03M in Q1 2015. 14 funds tracked by Wall St. Rank hold GLMD as of Q3 2016.

  • Craig A. Drill reported no remaining Galmed Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Craig A. Drill sold 14 Galmed Pharmaceuticals shares in Q3 2016, an estimated $90K.
  • Craig A. Drill first reported a position in Galmed Pharmaceuticals in Q1 2015 and held it in 4 quarters.
  • Craig A. Drill's Galmed Pharmaceuticals position peaked at $1.03M in Q1 2015.
  • 14 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q3 2016.

Based on Craig A. Drill's 13F filing for Q3 2016, filed 10 Nov 2016.